FUTURE THERAPIES, TESTED TODAY
AI-TWIN is an innovative biotech startup advancing personalized medicine through breakthrough discoveries in biomedical and clinical research.
By integrating human biology with cutting-edge microfabrication and organ-on-chip technologies, AI-TWIN is developing next-generation platforms for more precise and predictive therapies.
REDEFINING RESEARCH WITH HUMAN BIOLOGY ON A CHIP
AI-TWIN is pioneering the future of personalized medicine with its unique Biological Twin + Digital Twin approach.
We create patient-specific 3D multi-tissue models using the patient’s own cells, true Biological Twin, paired with AI-driven Digital Twin that interpret data and predict therapeutic response.
The result is a powerful platform ideal for:
- Accurate disease modeling
- Predictive testing of therapies
- Personalized treatment guidance
AI-TWIN is transforming how research translates into real impact for patients.
INNOVATION
At the core of AI-TWIN’s innovation is the convergence of Biological and Digital Twins, creating a powerful framework for generating predictive, patient-specific data.This enables the development of Clinical Trials on Chips, a new paradigm for evaluating drug efficacy and safety with unprecedented speed, precision, and ethical standards.
This breakthrough approach is set to reshape the pharmaceutical landscape, unlocking truly personalized clinical trials and accelerating the future of drug development.
PARTNERS
FUTURE THERAPIES, TESTED TODAY
AI-TWIN is an innovative biotech startup advancing personalized medicine through breakthrough discoveries in biomedical and clinical research.
By integrating human biology with cutting-edge microfabrication and organ-on-chip technologies, AI-TWIN is developing next-generation platforms for more precise and predictive therapies.
REDEFINING RESEARCH WITH HUMAN BIOLOGY ON A CHIP
AI-TWIN is pioneering the future of personalized medicine with its unique Biological Twin + Digital Twin approach.
We create patient-specific 3D multi-tissue models using the patient’s own cells, true Biological Twin, paired with AI-driven Digital Twin that interpret data and predict therapeutic response.
The result is a powerful platform ideal for:
- Accurate disease modeling
- Predictive testing of therapies
- Personalized treatment guidance
AI-TWIN is transforming how research translates into real impact for patients.
INNOVATION
At the core of AI-TWIN’s innovation is the convergence of Biological and Digital Twins, creating a powerful framework for generating predictive, patient-specific data.This enables the development of Clinical Trials on Chips, a new paradigm for evaluating drug efficacy and safety with unprecedented speed, precision, and ethical standards.
This breakthrough approach is set to reshape the pharmaceutical landscape, unlocking truly personalized clinical trials and accelerating the future of drug development.
PARTNERS
Ai-Twin srl
Sede legale e operativa
C.so Trieste, 15/A – 28100 Novara (NO)
C.F./P.IVA 02722210032
SDI SUBM70N
WHERE TO FIND US